What doesn't seem realistic? Do you not like the drug? The share structure? I don't think $4 common share price and $2 warrant price with 4 years until expiration is that absurd...have you seen what bio tech companies pay for companies like Kitov? Stage 3 drug, with great results and NDA submission this year, not sure what you don't like. Please share!